FIELD: medicine. SUBSTANCE: to correct hypoglycemic state it is suggested to apply synthesized peptides of human insulin which contain amino acid residues being the part of the site of insulin binding to cellular receptor; taken out of a group: -C-terminal peptide of insular A-chain (A12-A21); -C-terminal peptides of human insular B-chain containing 14-23 amino acid residues; -dimer which contains C-terminal peptide of A-chain (A18-A21) and C-terminal peptide of B-chain (B17-B30) connected by disulfide bridge and, also, their mixtures. EFFECT: prolonged action of suggested preparation. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE FRAGMENT SHOWING BIOLOGICAL ACTIVITY OF INSULIN | 1995 |
|
RU2078769C1 |
| ANALOG-AGONIST OF AMYLINE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, COMPOSITION EXHIBITING PROPERTIES OF AMYLINE AGONIST | 1992 |
|
RU2130463C1 |
| PHARMACEUTICAL COMPOSITION | 2013 |
|
RU2670106C2 |
| COMPOSITION FOR TREATING DIABETES, CONTAINING LONG-ACTING INSULIN CONJUGATE AND LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE | 2012 |
|
RU2606840C2 |
| GLUCAGON ANALOGUES, POSSESSING HIGHER SOLUBILITY AND STABILITY IN BUFFERS WITH PHYSIOLOGICAL Ph VALUES | 2009 |
|
RU2560254C2 |
| HUMAN OXYNTOMODULIN, ITS APPLICATION, MEDICATION BASED THEREON AND METHOD OF APPLYING MEDICATION FOR TREATMENT AND PREVENTION OF HYPERGLYCEMIA | 2009 |
|
RU2524204C2 |
| NEW VERSION OF EXENDIN OR ITS CONJUGATE | 2010 |
|
RU2528734C2 |
| INSULIN ANALOGUES WITH ACYL AND ALKYLENE GLYCOL GROUP | 2008 |
|
RU2514430C2 |
| IMPROVING THE RECOVERY FUNCTION OF THE CARDIOVASCULAR SYSTEM IN ISCHEMIA TETRADECAPEPTIDES | 2017 |
|
RU2648846C1 |
| DIPEPTIDYL PEPTIDASE-4 INHIBITOR FOR TREATMENT OF TYPE 2 DIABETES | 2015 |
|
RU2628573C2 |
